Insiders Syndax Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
21.97 ^USD	-1.83%		+0.50%	+1.67%

08/05	Syndax Pharmaceuticals Q1 Net Loss Widens	MT
08/05	Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024

Syndax Pharmaceuticals, Inc. Announces Executive Changes	18/03	CI
Insider Sell: Syndax Pharmaceuticals	10/23/10	MT
Insider Sell: Syndax Pharmaceuticals	03/23/03	MT
Insider Sell: Syndax Pharmaceuticals	11/23/11	MT
Insider Sell: Syndax Pharmaceuticals	10/23/10	MT
Insider Sell: Syndax Pharmaceuticals	11/23/11	MT
Syndax Pharmaceuticals, Inc. Announces Executive Changes	09/23/09	CI
Insider Sell: Syndax Pharmaceuticals	13/23/13	MT
Syndax Pharmaceuticals, Inc. Announces Appointment of Neil Gallagher as President, Head of Research and Development	30/23/30	CI
Insider Sell: Syndax Pharmaceuticals	15/23/15	MT
Insider Sell: Syndax Pharmaceuticals	14/23/14	MT
Insider Sell: Syndax Pharmaceuticals	03/22/03	MT
Syndax Pharmaceuticals Names Steve Sabus Chief Commercial Officer	02/22/02	MT
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer	02/22/02	CI
Insider Sell: Syndax Pharmaceuticals	08/22/08	MT
Insider Sell: Syndax Pharmaceuticals	22/22/22	MT
Insider Sell: Syndax Pharmaceuticals	17/22/17	MT
Insider Sell: Syndax Pharmaceuticals	17/22/17	MT
Insider Sell: Syndax Pharmaceuticals	09/22/09	MT
Syndax Pharmaceuticals Names Keith Goldan as Chief Financial Officer	13/22/13	MT

No results for this search